TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PEN

Penumbra Inc

Healthcare · Medical Devices

317.50$ +0.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Penumbra Inc (PEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,975 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
297 308 418 417 459 477 490 499 501 515 569 585 614 666 664 780 810 823 841 910 973 1,244 1,302 1,328 1,322 1,371 1,395 1,433 1,468 1,556 1,580 1,535 1,479 1,533 1,593 1,675 1,744 1,827 1,898 1,975
267 264 372 365 372 382 388 392 398 411 423 435 451 463 454 576 590 618 635 653 668 681 690 718 724 756 786 828 868 915 935 944 892 951 1,000 1,065 1,142 1,217 1,275 1,344
16 13 109 77 66 51 53 60 48 68 96 77 112 73 72 134 80 70 56 82 66 59 68 58 55 70 95 114 101 167 223 288 280 324 376 422 321 187 241 205
142 129 232 219 219 215 215 207 194 201 195 187 194 189 168 278 269 265 243 239 267 255 240 204 184 188 199 221 249 289 313 340 291 340 379 425 470 545 616 659
42 43 50 49 48 58 65 74 80 82 95 99 102 106 104 98 113 115 126 137 120 134 143 187 189 203 207 209 207 202 192 201 176 168 168 176 183 190 183 190
70 73 79 81 91 95 95 98 110 116 122 133 140 153 166 183 192 220 245 255 258 264 274 296 320 334 344 359 374 388 398 374 393 407 416 428 432 432 439 443
16 21 23 24 28 31 32 34 34 35 78 80 87 132 141 143 65 48 50 181 57 227 60 276 64 291 65 66 282 – – – 270 268 275 286 295 317 – –
0.0 0.0 0.0 0.0 7.4 8.2 8.4 8.0 7.9 7.8 7.7 7.8 7.5 7.7 7.5 7.7 8.0 8.4 8.0 8.1 7.9 166 166 166 165 166 166 166 166 166 166 166 166 166 166 167 167 167 167 167
0.0 0.0 0.0 0.0 24 24 28 27 27 27 27 26 25 25 25 11 11 11 10 9.9 9.5 91 88 86 83 81 79 76 73 63 68 7.0 6.9 6.5 6.5 6.6 6.4 6.8 5.9 5.7
43 42 45 44 75 76 75 74 92 93 132 131 147 180 176 157 191 185 190 237 289 290 342 358 348 372 371 366 364 377 376 373 375 382 380 381 386 399 425 444
37 36 39 38 51 52 50 50 65 66 69 70 86 91 88 78 108 106 112 108 116 123 130 146 138 145 146 144 145 151 153 151 153 158 159 158 170 183 212 234
– – – – – – – – – – 3.7 3.7 4.0 8.3 6.9 5.5 5.8 6.0 6.3 7.8 9.2 10.0 10 11 11 12 12 13 13 13 14 14 14 15 15 15 16 16 17 17
3.6 4.1 5.0 4.3 5.8 6.8 7.4 7.4 8.9 8.2 7.7 8.7 12 15 16 14 15 14 15 14 14 13 14 23 25 27 28 26 28 27 32 33 33 31 31 28 30 35 44 45
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 46 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
254 267 373 373 384 400 415 425 409 422 437 454 467 486 489 625 622 641 655 679 691 954 959 970 974 999 1,024 1,067 1,104 1,179 1,204 1,161 1,104 1,151 1,213 1,294 1,359 1,428 1,474 1,531
-18 -2.7 -5.8 -7.3 -7.1 2.0 8.0 21 2.4 9.1 20 36 48 58 58 46 37 41 52 62 71 46 46 42 40 44 52 71 81 135 146 86 26 60 99 144 190 238 270 305
34 31 32 33 36 36 36 36 34 36 36 36 36 36 36 35 36 37 38 38 38 37 39 38 38 39 39 39 39 39 39 39 39 39 39 39 39 39 40 40

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?